$21.440
-0.041 (-0.19%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
Soll ich Braveheart Bio, Inc.-Aktien kaufen?
Braveheart Bio, Inc. (BRVE) appears to be a good buy right now due to its recent price of $21.44, which is significantly below the analyst price targets ranging from $40 to $48. The stock has shown a strong 5-day change of +14.59%, indicating positive momentum. Additionally, the RSI is at 65.87, suggesting that while the stock is nearing overbought territory, it still has room for growth. The main risk is the substantial net loss reported for Q2 2026 of $18.60 million, which could impact future performance if not managed effectively.
BRVE schloss am Friday bei $21.44, nachdem der Kurs -0.19% fallen
Braveheart Bio, Inc. (BRVE) last closed at $21.44, losing -0.19%. These facts feed the 1-day and 1-week BRVE price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Braveheart Bio, Inc. (BRVE) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Saisonalitätsanalyse für BRVE
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.